A Phase 2 Study of Multiparametric Magnetic Resonance Imaging-Guided High-Dose Response-Adaptive Radiation Therapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma: Results From an Interim Analysis is a research paper published in International Journal of Radiation Oncology*Biology*Physics (2025). On theSindex it has a DataRank of 0.219. It has been cited 3 times, with 2 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0.0109
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 2 citers.
National Cancer Institute
Grant: R50CA276015
NCI NIH HHS
Grant: P30 CA046592
NCI NIH HHS
Grant: P01 CA059827
Damon Runyon Cancer Research Foundation
Ben and Catherine Ivy Foundation
National Institute of Neurological Disorders and Stroke
Rogel Cancer Center, University of Michigan
University of Michigan
V Foundation for Cancer Research
National Institutes of Health
Sontag Foundation
Spectrum
FWCI
2.27
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords